ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 18-24

  Louiset, Estelle ^a   Gobet, Françoise ^b   Libé, Rossella ^c   Horvath, Anelia ^d   Renouf, Sylvie ^a   Cariou, Juliette ^b   Rothenbuhler, Anya ^d   Bertherat, Jérôme ^c   Clauser, Eric ^e   Grise, Philippe ^b   Stratakis, Constantine A ^d   Kuhn, Jean Marc ^a   Lefebvre, Hervé ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c CNRS   (France)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e Cochin Hospital ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FLUDROCORTISONE; HYDROCORTISONE; MESSENGER RNA; PROTEIN PDE11A; PROTEIN PDE8B; PROTEIN PRKAR1A; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CUSHING SYNDROME; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HYPERCORTISOLISM; IN VITRO STUDY; IN VIVO STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 75149177071     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0881     Document Type: Conference Paper

References (27)

1. Christopoulos S, Bourdeau I, Lacroix A 2005 Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm Res 64:119-131
2. Stratakis CA, Boikos SA 2007 Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab 3:748-757
3. Bossis I, Voutetakis A, Bei T, Sandrini F, Griffin KJ, Stratakis CA 2004 Protein kinase A and its role in human neoplasia: the Carney complex paradigm. Endocr Relat Cancer 11:265-280
4. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhina L, Libè R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I, Stratakis CA 2006 Agenome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38:794-800
5. Horvath A, Mericq V, Stratakis CA 2008 Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 358:750-752
6. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA 1999 Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 131:585-591
7. Stratakis CA, Kirschner LS, Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046
8. Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J 2002 Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 71:1433-1442
9. Libé R, Fratticci A, Coste J, Tissier F, Horvath A, Ragazzon B, Rene-Corail F, Groussin L, Bertagna X, Raffin-Sanson ML, Stratakis CA, Bertherat J 2008 Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res 14:4016-4024
10. Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libè R, Patronas Y, Robinson-White A, Remmers E, Bertherat J, Nesterova M, Stratakis CA 2008 A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 16:1245-1253
11. Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Barrande G, Bertherat J, Vaudry H, Lefebvre H 2006 Expression of serotonin 7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 91:4578-4586
12. 4 receptor subtype. Neuroscience 47:999-1007
13. Vassiliadi D, Tsagarakis S 2007 Unusual causes of Cushing's syndrome. Arq Bras Endocrinol Metabol 51:1245-1252
14. Ney RL, Hammond W, Wright L, Davis WW, Acker J, Bartter FC 1966 Studies in a patient with an ectopic adrenocortical tumor. J Clin Endocrinol Metab 26:299-304
15. Raith L, Karl HJ 1969 Pregnancy in ectopic adrenal carcinoma. Horm Metab Res 1:149-150
16. Wallace EZ, Leonidas JR, Stanek AE, Avramides A 1981 Endocrine studies in a patient with functioning adrenal rest tumor of the liver. Am J Med 70:1122-1125
17. Contreras P, Altieri E, Liberman C, Gac A, Rojas A, Ibarra A, Ravanal M, Serón-Ferré M 1985 Adrenal rest tumor of the liver causing Cushing's syndrome: treatment with ketoconazole preceding an apparent surgical cure. J Clin Endocrinol Metab 60:21-28
18. Adeyemi SD, Grange AO, Giwa-Osagie OF, Elesha SO 1986 Adrenal rest tumour of the ovary associated with isosexual precocious pseudopuberty and cushingoid features. Eur J Pediatr 145:236-238
19. Leibowitz J, Pertsemlidis D, Gabrilove JL 1998 Recurrent Cushing's syndrome due to recurrent adrenocortical tumor - fragmentation or tumor in ectopic adrenal tissue? J Clin Endocrinol Metab 83:3786-3789
20. Ayala AR, Basaria S, Udelsman R, Westra WH, Wand GS 2000 Corticotropin-independent Cushing's syndrome caused by an ectopic adrenal adenoma. J Clin Endocrinol Metab 85:2903-2906
21. Jain SH, Sadow PM, Nosé V, Dluhy RG 2008 A patient with ectopic cortisol production derived from malignant testicular masses. Nat Clin Pract Endocrinol Metab 4:695-700
22. Song IH, Buttgereit F 2006 Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 246:142-146
23. Louiset E, Stratakis CA, Perraudin V, Griffin KJ, Libé R, Cabrol S, Fève B, Young J, Groussin L, Bertherat J, Lefebvre H 2009 The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. J Clin Endocrinol Metab 94:2406-2413
24. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA 2003 Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 63:5308-5319
25. Mancini T, Kola B, Mantero F, Arnaldi G 2003 Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin. J Clin Endocrinol Metab 88:1994-1998
26. New MI 2006 Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4205-4214
27. Penhoat A, Jaillard C, Saez JM 1989 Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 86:4978-4981